Literature DB >> 16952399

Cost-of-illness studies of depression: a systematic review.

Melanie Luppa1, Sven Heinrich, Matthias C Angermeyer, Hans-Helmut König, Steffi G Riedel-Heller.   

Abstract

BACKGROUND: Depression is a very common disease with substantial economic consequences. This paper reviews all published cost-of-illness studies of depression worldwide.
METHODS: A systematic search of cost-of-illness studies of depression in the databases MEDLINE, Web of Science, Cochrane Library, and PSYNDEXplus was conducted. Identified studies were classified by their basic characteristics. Costs reported were inflated in original currency to the year 2003 and then converted into US-dollar using purchasing power parities (US$ PPP). Additionally, national-costs were converted in costs per case and per inhabitant.
RESULTS: 24 papers with notable methodical differences were identified and classified by their basic characteristics. Summary estimates from the studies for the average annual costs per case ranged from $1000 to $2500 for direct costs, from $2000 to $3700 for morbidity costs and from $200 to $400 for mortality costs. The basic quantity of interest in COI-studies of depression was stated. LIMITATIONS: Methodical differences limited comparison substantially.
CONCLUSIONS: Depression is associated with a high economic burden. Conducting COI-studies of depression along the line noted in the review could help provide the opportunity to expose differences in costs associated with different approaches to disease management.

Entities:  

Mesh:

Year:  2006        PMID: 16952399     DOI: 10.1016/j.jad.2006.07.017

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  95 in total

1.  Using electronic data sources to understand the determinants of psychiatric visit non-adherence.

Authors:  Patricia E Alafaireet; Howard L Houghton; Grant T Savage; Yang Gong
Journal:  AMIA Annu Symp Proc       Date:  2009-11-14

Review 2.  Examining antidepressant drug response by smoking status: why is it important and how often is it done?

Authors:  Andrea H Weinberger; Sherry A McKee; Marina R Picciotto; Carolyn M Mazure
Journal:  J Psychopharmacol       Date:  2010-12-17       Impact factor: 4.153

Review 3.  Perceived job insecurity, unemployment and depressive symptoms: a systematic review and meta-analysis of prospective observational studies.

Authors:  T J Kim; O von dem Knesebeck
Journal:  Int Arch Occup Environ Health       Date:  2015-12-29       Impact factor: 3.015

4.  Neural response to reward and depressive symptoms in late childhood to early adolescence.

Authors:  Jennifer N Bress; Ezra Smith; Dan Foti; Daniel N Klein; Greg Hajcak
Journal:  Biol Psychol       Date:  2011-10-18       Impact factor: 3.251

5.  Reward dysfunction in major depression: multimodal neuroimaging evidence for refining the melancholic phenotype.

Authors:  Dan Foti; Joshua M Carlson; Colin L Sauder; Greg H Proudfit
Journal:  Neuroimage       Date:  2014-07-01       Impact factor: 6.556

6.  Incarcerating juveniles in adult prisons as a factor in depression.

Authors:  Irene Y H Ng; Xiaoyi Shen; Helen Sim; Rosemary C Sarri; Elizabeth Stoffregen; Jeffrey J Shook
Journal:  Crim Behav Ment Health       Date:  2011-02

7.  Time-Frequency Reward-Related Delta Prospectively Predicts the Development of Adolescent-Onset Depression.

Authors:  Brady D Nelson; Zachary P Infantolino; Daniel N Klein; Greg Perlman; Roman Kotov; Greg Hajcak
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-08-07

8.  Cost-effectiveness analysis of cognitive behaviour therapy for treatment of minor or mild-major depression in elderly patients with type 2 diabetes: study protocol for the economic evaluation alongside the MIND-DIA randomized controlled trial (MIND-DIA CEA).

Authors:  Nadja Chernyak; Frank Petrak; Kristin Plack; Martin Hautzinger; Matthias J Müller; Guido Giani; Andrea Icks
Journal:  BMC Geriatr       Date:  2009-07-01       Impact factor: 3.921

9.  Effectiveness of a novel integrative online treatment for depression (Deprexis): randomized controlled trial.

Authors:  Björn Meyer; Thomas Berger; Franz Caspar; Christopher G Beevers; Gerhard Andersson; Mario Weiss
Journal:  J Med Internet Res       Date:  2009-05-11       Impact factor: 5.428

10.  Health costs in patients treated for depression, in patients with depressive symptoms treated for another chronic disorder, and in non-depressed patients: a two-year prospective cohort study in anthroposophic outpatient settings.

Authors:  Harald J Hamre; Claudia M Witt; Anja Glockmann; Renatus Ziegler; Gunver S Kienle; Stefan N Willich; Helmut Kiene
Journal:  Eur J Health Econ       Date:  2010-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.